Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.
about
Sympathoadrenal Activation is Associated with Acute Traumatic Coagulopathy and Endotheliopathy in Isolated Brain InjurySystems biology approaches for discovering biomarkers for traumatic brain injuryTargeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain InjuryIdentification of serum microRNA signatures for diagnosis of mild traumatic brain injury in a closed head injury model.Fluid Biomarkers of Traumatic Brain Injury and Intended Context of UseBlood biomarkers for brain injury: What are we measuring?Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot studyAcute death of astrocytes in blast-exposed rat organotypic hippocampal slice culturesFunctional, Structural, and Neurotoxicity Biomarkers in Integrative Assessment of Concussions.Assessing neuro-systemic & behavioral components in the pathophysiology of blast-related brain injury.A Historical Perspective on Sports Concussion: Where We Have Been and Where We Are Going.Potential Blood-based Biomarkers for Concussion.Biomarkers and acute brain injuries: interest and limitsCharacterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury.Clinical evidence of inflammation driving secondary brain injury: a systematic review.Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.Concussion guidelines step 1: systematic review of prevalent indicators.Multivariate analysis of traumatic brain injury: development of an assessment score.Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion.Temporal MRI characterization, neurobiochemical and neurobehavioral changes in a mouse repetitive concussive head injury model.Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.The diagnosis of traumatic brain injury on the battlefield.Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head TraumaH-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patientsCurrent status of fluid biomarkers in mild traumatic brain injuryIn Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed TomographyCirculating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.Mild Traumatic Brain Injury among the Geriatric PopulationAssessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.
P2860
Q26779503-EC0A7AD4-BBC8-438A-A300-03896F24BFA0Q26824124-883859A4-D01B-43A3-9516-557363557F8CQ27304584-94B5B630-C077-4BEB-9D2C-D466DE3E46C6Q27331576-701F2072-6875-4DFB-BD10-A7C0CA47FF5CQ28066813-8982CDAD-4D4D-4C7F-8449-F750F56D4DFAQ28067275-65AC3593-E824-470D-B3C8-EAA35173E6DBQ28535264-09F17ADA-8848-4368-B3F6-38D6CEC6F517Q30361334-1B482116-057D-4614-AC47-8128506CEBA6Q30372117-CA99344E-FCD2-4C9C-A5C4-ED2E3E957F48Q30446201-3AEAA36D-6654-4463-B426-21F50A564878Q31096810-CD1CBD05-885E-4459-A84F-E8A0316E7C40Q31119100-D747EA4C-A33B-4EDD-AE6D-6FACB08506B8Q33752053-3D5369DC-7AEB-4841-A024-5B52D38E825DQ33888244-8D988FC0-8220-4D68-BF0D-EDEAC739C535Q33916315-50A4DC07-EBB6-4251-BFF3-359045287B3CQ34471118-3F02B63A-D3F4-4574-9524-CF7BB3169684Q34788054-30A32ECE-0193-4D73-9EF7-15FC39C96320Q34978220-1F7C2F7E-D96E-4215-89CB-28DBC4460AFBQ35131093-363EAFD4-B28C-4A8C-9927-080575608D50Q35142344-306B7B51-98EE-4BC0-8B6B-B909782EC15DQ35203701-A620812A-CCAA-4722-8A18-0A54046EDF92Q35229002-7535261E-5ECC-49C9-8202-81862CEEF291Q35376450-A5BF4AEC-291B-4F20-AC3B-256801CE4DCDQ35589772-DFEF7128-52AF-48FA-B3F4-34E7EB3EBDB0Q35709639-D6E28FE3-5DBF-4BC5-A5A8-8B734B1395D1Q35977643-907AFCFA-B6BD-4605-A8C8-CE3038558DC4Q35993214-46F3C238-D230-4C9E-94E4-17323B4074B4Q36026050-654A9D53-57AA-4D67-91B1-E406C5A5B3ABQ36079583-2809D079-0372-43AD-997A-D9F10B74EC2FQ36146948-2FFC86F4-84AD-4239-B5E2-EE7CF82CDDB0Q36264759-CEACD732-6561-46C8-BC59-FD87BFBB1721Q36349690-C4BA6CFC-7BEF-4B64-B279-CDF7CB633FA2Q36399829-89C88C78-82AB-4A72-9427-29DCCF9C9B0AQ36424343-1C2C6D3C-492A-4A6F-961C-C30ABC00A669Q36427671-69323140-B3BA-4300-8419-5693C46F000DQ36489519-E29338D5-763E-42B0-B288-65C021813A03Q36489525-9DBEEBC4-B912-4CB1-86A7-9493967CA471Q36689419-EF73F322-7B26-4734-B811-D75E08D94988Q36761939-C6C10F7A-9619-47EF-AB1E-CF358BD29069Q36796090-56F7D075-100C-44F9-A17A-EA6EAD30086D
P2860
Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Elevated levels of serum glial ...... nd neurosurgical intervention.
@en
Elevated levels of serum glial ...... nd neurosurgical intervention.
@nl
type
label
Elevated levels of serum glial ...... nd neurosurgical intervention.
@en
Elevated levels of serum glial ...... nd neurosurgical intervention.
@nl
prefLabel
Elevated levels of serum glial ...... nd neurosurgical intervention.
@en
Elevated levels of serum glial ...... nd neurosurgical intervention.
@nl
P2093
P2860
P50
P1476
Elevated levels of serum glial ...... nd neurosurgical intervention.
@en
P2093
Claudia S Robertson
Frank C Tortella
Jason A Demery
Jay L Falk
Jixiang Mo
Kara Schmid
Lawrence M Lewis
Linda Papa
Linnet Akinyi
Ming Cheng Liu
P2860
P304
P356
10.1016/J.ANNEMERGMED.2011.08.021
P407
P577
2011-11-08T00:00:00Z